Congress of psychiatry

Preisverleihung:  
DGPPN-Posterpreise
Laudation: 
Andreas Küthmann, Germany

SPECIAL
 SESSIONS
35
Mon, 9 Oct 2017
13:30– 15:00 
|
 Hall A3
Is the Dodo Verdict valid – are all psychotherapies 
equally eff ective?
Chairs:  
Elisabeth Schramm, Germany
 Robert Mestel, Germany
The Dodo-Bird-Verdict is right
Proponent:  
Bruce Wampold, USA
The Dodo-Bird-Verdict is not proven yet
Opponent:  
Pim Cuijpers, The Netherlands
15:15 – 16:45 
|
 Hall Paris 1
 RDoC: der Königsweg zu einer neuen 
psychiatrischen Taxonomie?
Chair:  
Peter Falkai, Germany
Proponent:  
Henrik Walter, Germany
Opponent:  
Henning Saß, Germany
Tue, 10 Oct 2017
10:00 – 11:30 
|
 Hall Helsinki 2
 Macht die Digitalisierung Ärzte und Therapeu-
ten überfl üssig?
Chairs:  
Iris Hauth, Germany
 Christine Knaevelsrud, Germany
Proponent:  
Martin Bohus, Germany
Opponent:  
Harald J. Freyberger, Germany
10:30 – 11:30 
|
 Hall A8
Suicide can be prevented by psychiatrists
Chairs:  
Fritz Hohagen, Germany
 Pavel Alfi mov, Russia
Proponent:  
Maria A. Oquendo, USA
Opponent:  
Michael Davidson, Israel
11:45 – 13:15 
|
 Hall Helsinki 2
 Off ene Psychiatrie – die Lösung aller Probleme?
Chairs:  
Christian Kieser, Germany
 Tilman Steinert, Germany
Proponent:  
Karl H. Beine, Germany
Opponent:  
Thomas Pollmächer, Germany
Wed, 11 Oct 2017
17:15 – 18:45 
|
 Hall A5
This house believes that mental health promotion 
should start in adulthood
Chairs:  
Andrea Pfennig, Germany
 Uttam Garg, India
Proponent:  
Avdesh Kumar Sharma, India
Opponent:  
Bennett Leventhal, USA
Pro-Con-Debates
WPA 
General assembly 
Tue, 10 Oct 2017
08:45 – 14:50 
Hotel Pullman
Schweizerhof

SPECIAL
 SESSIONS
36
Mon, 9 Oct 2017
08:15 – 09:45 
|
 Hall A3
 Autismus-Spektrum-Störungen im Kindes-, 
Jugend- und Erwachsenenalter
Chairs: 
Kai Vogeley, Germany 
Helmut Remschmidt, Germany
Kinder und Jugendliche mit hochfunktionalem 
Autismus
Helmut Remschmidt, Germany
Autismus-Spektrum-Störungen im Erwachsenenalter
Kai Vogeley, Germany
10:00 – 11:30 
|
  Hall  A6 / A7
 Zwangsstörungen
Chairs: 
Fritz Hohagen, Germany 
Ulrich Voderholzer, Germany
Psychotherapie der Zwangsstörungen
Fritz Hohagen, Germany
State-of-the-Art der Pharmakotherapie bei Zwangs-
störungen und neue therapeutische Entwicklungen
Ulrich Voderholzer, Germany
10:00 – 11:30 
|
 Hall A3
 Dissoziative Störungen
Chairs: 
Carsten Spitzer, Germany 
Kathlen Priebe, Germany
11:45 – 13:15 
|
 Hall A3
 Die Psychotherapie der Psychosen
Chairs: 
Stefan Klingberg, Germany 
Andreas Bechdolf, Germany
Über Wahn reden? Rückfälle durch Psychotherapie 
verhindern? Evidenzbasierte Psychotherapie bei  
psychotischen Störungen
Stefan Klingberg, Germany
Erste psychotische Symptome bewältigen – evidenz-
basierte Psychotherapie bei Personen mit erhöhtem 
Psychoserisiko und bei Ersterkrankten
Andreas Bechdolf, Germany
11:45 – 13:15 
|
 Hall A1
70 years of lithium research: from serendipity to 
gold standard in mood disorders
Chairs: 
Michael Bauer, Germany 
Michael Gitlin, USA
History and current role of lithium for treatment of 
mood disorders
Michael Bauer, Germany
Practical guide of lithium therapy and management 
of side effects
Michael Gitlin, USA
13:30 – 15:00 
|
 Hall A8
 Posttraumatische Belastungsstörungen
Chairs: 
Regina Steil, Germany 
Andreas Maercker, Switzerland
Empirisch gestützte Psychotherapien der PTBS
Regina Steil, Germany
Risiko-, Schutzfaktoren und psychische Prozesse der 
posttraumatischen Belastungsstörungen
Andreas Maercker, Switzerland
15:15 – 16:45 
|
 Hall A3
 Sexuelle Störungen
Chairs: 
Michael M. Berner, Germany 
Peer Briken, Germany
Sexuelle Funktionsstörungen und medikamentenin-
duzierte Sexualstörungen
Michael M. Berner, Germany
Paraphile und hypersexuelle Störungen
Peer Briken, Germany
17:00 – 18:30 
|
  Hall  A6 / A7
Recent updates on the efficacy of psychodynamic 
psychotherapy in 2017
Chairs: 
Jacques P. Barber, USA 
Richard Summers, USA
What do we know about the efficacy of individual 
dynamic therapy?
Jacques P. Barber, USA
What do we know about the efficacy of group 
dynamic therapy?
Bernhard Strauß, Germany
State-of-the-Art-Symposia

SPECIAL
 SESSIONS
37
17:00 – 18:30 
|
 Hall A3
 Schlafstörungen
Chairs: 
Dieter Riemann, Germany 
Thomas Pollmächer, Germany
Schlaf, Schlaflosigkeit und psychische Erkrankungen
Dieter Riemann, Germany
Tagesmüdigkeit, Tagesschläfrigkeit – Wechsel-
wirkungen mit psychischen Erkrankungen
Thomas Pollmächer, Germany
Tue, 10 Oct 2017
08:15 – 09:45 
|
 Hall A2
 Gerontopsychiatrie: Depression und Delir
Chairs: 
Vjera Holthoff-Detto, Germany 
Michael Hüll, Germany
Komplexe Behandlungsstrategien der Altersdepression
Vjera Holthoff-Detto, Germany
Delire bei älteren Menschen: vermeiden, erkennen, 
behandeln
Michael Hüll, Germany
10:00 – 11:30 
|
 Hall A3
 ADHS in der Lebensspanne
Chairs: 
Tobias Banaschewski, Germany 
Alexandra Philipsen, Germany
Aufmerksamkeitsdefizit- / Hyperaktivitätsstörungen 
im Kindes- und Jugendalter – Update
Tobias Banaschewski, Germany
ADHS im Erwachsenenalter – Diagnostik und  
Behandlung
Alexandra Philipsen, Germany
11:45 – 13:15 
|
 Hall A8
 Verhaltensabhängigkeiten
Chairs: 
Tagrid Leménager, Germany 
Astrid Müller, Germany
Das virtuelle Selbst – Ätiologie, neurobiologische 
Korrelate sowie therapeutische Implikationen zur 
Internetsucht
Tagrid Leménager, Germany
Kaufsucht
Astrid Müller, Germany
13:30 – 15:00 
|
 Hall A5
Recognizing and diagnosing autoimmune 
encephalitis
Chairs: 
Ludger Tebartz van Elst, Germany 
Josef Priller, Germany
Psychosis and antibodies to synaptic receptors
Josep Dalmau, Spain
Antibody findings in psychiatric patients – a critical 
analysis of the state-of-the-art
Angela Vincent, United Kingdom
13:30 – 15:00 
|
 Hall A1
 Essstörungen
Chairs:  
Iris Pollmann, Germany 
Beate Herpertz-Dahlmann, Germany
Bulimia nervosa, Binge-Eating Störung, Night-Eating- 
Syndrom und Adipositas
Iris Pollmann, Germany
Anorexia nervosa – State-of-the-Art
Beate Herpertz-Dahlmann, Germany
15:15 – 16:45 
|
 Hall A3
 Alkoholabhängigkeit
Chairs: 
Falk Kiefer, Germany 
Andreas Heinz, Germany
Aktuelle Entwicklungen in der Therapie der  
Alkoholabhängigkeit
Falk Kiefer, Germany
Neurobiologie und Pharmakotherapie der  
Alkoholabhängigkeit
Andreas Heinz, Germany
15:15 – 16:45 
|
 Hall A4
 Therapie im Maßregelvollzug
Chairs: 
Beate Eusterschulte, Germany 
Birgit von Hecker, Germany
Behandlung psychisch kranker Rechtsbrecher:  
Theorie und Praxis der Kriminaltherapie
Beate Eusterschulte, Germany
Therapie im Maßregelvollzug – die Behandlung in 
der Entziehungsanstalt gemäß § 64 StGB
Birgit von Hecker, Germany
17:00 – 18:30 
|
 Hall A3
Persistent and treatment-resistant depressive 
disorders
Chairs: 
Elisabeth Schramm, Germany 
Mazda Adli, Germany
Psychotherapy
Elisabeth Schramm, Germany
Pharmacotherapy
Mazda Adli, Germany

SPECIAL
 SESSIONS
38
State-of-the-Art-Symposia
17:00 – 18:30 
|
 Hall A5
 Schwierig zu behandelnde Schizophrenie
Chairs: 
Stefan Leucht, Germany 
Gerhard Gründer, Germany
Pharmakologische Behandlung der Schizophrenie: 
Darstellung der evidenzbasierten Fakten
Stefan Leucht, Germany
Pharmakologische Behandlung der Schizophrenie: 
Diskussion praxisrelevanter Fragen
Gerhard Gründer, Germany
Wed, 11 Oct 2017
10:00 – 11:30 
|
 Hall A1
 Tic-Störungen
Chairs: 
Kirsten Müller-Vahl, Germany 
Irene Neuner, Germany
Tourette-Syndrom und Tics – Klinik und Verhaltens-
therapie
Kirsten Müller-Vahl, Germany
Tourette-Syndrom und Tics – Therapieoptionen me-
dikamentös und mittels tiefer Hirnstimulation
Irene Neuner, Germany
10:00 – 11:30 
|
 Hall A4
 Schizophrenie – Pharmakotherapie
Chairs: 
Martin Lambert, Germany 
W. Wolfgang Fleischhacker, Austria
Erwünschte Wirkungen von Antipsychotika
Martin Lambert, Germany
Unerwünschte Wirkungen von Antipsychotika
W. Wolfgang Fleischhacker, Austria
11:45 – 13:15 
|
  Hall  A6 / A7
 Angststörungen
Chairs: 
Katharina Domschke, Germany 
Jürgen Hoyer, Germany
Angststörungen – Update Neurobiologie und Phar-
makotherapie
Katharina Domschke, Germany
Update Psychotherapie und Wirkmechanismen
Jürgen Hoyer, Germany
13:30 – 15:00 
|
 Hall A1
 Anhaltende Trauerstörung
Chairs: 
Rita Rosner, Germany 
Hansjörg Znoj, Switzerland
Trennung, Tod und Trauer: zur Psychologie des 
Verlusterlebens
Hansjörg Znoj, Switzerland
Diagnose und spezifische Behandlung von anhalten-
den komplexen Trauerreaktionen
Rita Rosner, Germany
15:15 – 16:45 
|
 Hall A3
Psychotic disorders
Chairs: 
Peter Falkai, Germany 
Christoph Correll, USA
Non-pharmacological interventions in schizophre-
nia: state-of-the-art and further directions
Peter Falkai, Germany
Pharmacotherapy for people with schizophrenia: 
weighing the options
Christoph Correll, USA
15:15 – 16:45 
|
 Hall A2
 Suizidalität
Chairs: 
Ulrich Hegerl, Germany 
Manfred Wolfersdorf, Germany
Epidemiologie: Verursachung und neueste Trends
Ulrich Hegerl, Germany
Risikoeinschätzung und klinisches Management
Manfred Wolfersdorf, Germany
17:00 – 18:30 
|
 Hall A1
 Bipolare Störungen
Chairs: 
Thomas E. Schläpfer, Germany 
Michael Bauer, Germany
Bipolare Störungen – Psychoedukation und neurobi-
ologische Grundlagen
Thomas E. Schläpfer, Germany
Behandlung bipolarer Störungen
Michael Bauer, Germany

SPECIAL
 SESSIONS
39
17:00 – 18:30 
|
 Hall A2
 Somatoforme Störungen
Chairs:  
Peter Henningsen, Germany
 Winfried Rief, Germany
Somatoforme Störungen, somatische Belas-
tungsstörungen: neue Konzepte, Klassifi kation 
und Störungsmechanismen
 Winfried Rief, Germany
Management der somatischen Belastungsstörung
 Peter Henningsen, Germany
Thu, 12 Oct 2017
08:15 – 09:45 
|
  Hall  A6 / A7
 Ätiologie und Behandlung der Persönlich-
keitsstörungen
Chairs:  
Sabine C. Herpertz, Germany
 Peter Fiedler, Germany
Funktionsbeeinträchtigungen als Targets modularer 
Psychotherapie
 Sabine C. Herpertz, Germany
Die Bedeutung der Komorbiditätsforschung für die 
Behandlungsplanung
 Peter Fiedler, Germany
10:00 – 11:30 
|
  Hall  A6 / A7
 Borderline-Persönlichkeitsstörungen
Chairs:  
Martin Bohus, Germany
 Klaus Lieb, Germany
Epidemiologie, Ätiologie und Diagnostik der Border-
line-Persönlichkeitsstörung
 Martin Bohus, Germany
Evidenzbasierte Psycho- und Pharmakotherapie der 
Borderline-Persönlichkeitsstörung
 Klaus Lieb, Germany
10:00 – 11:30 
|
 Hall A4
 Psychosomatische Aspekte in der Behandlung 
der Adipositas
Chairs:  
Stephan Herpertz, Germany
 Stephan Zipfel, Germany
Psychosomatische Aspekte der Adipositas unter be-
sonderer Berücksichtigung der Adipositas-Chirurgie
 Stephan Herpertz, Germany
Psychotherapie und Verhaltensmodifi kation bei der 
Adipositas
 Stephan Zipfel, Germany
11:45 – 13:15 
|
 Hall A5
 Demenzen
Chairs:  
Lutz Frölich, Germany
 Frank Jessen, Germany
11:45 – 13:15 
|
 Hall A2
 Psychische Erkrankung und Schwangerschaft
Chairs:  
Anke Rohde, Germany
 Christof Schaefer, Germany
Peripartales Management zur Rezidivprophylaxe bei 
psychisch kranken Schwangeren
 Anke Rohde, Germany
Auswirkungen von Psychopharmaka auf die kindli-
che Entwicklung
 Christof Schaefer, Germany
13:30 – 15:00 
|
 Hall A8
 Unipolare Depression
Chairs:  
Max Schmauß, Germany
 Mathias Berger, Germany
Pharmakotherapie der unipolaren Depression
 Max Schmauß, Germany
Psychotherapie in der Depressionsbehandlung
 Mathias Berger, Germany
13:30 – 15:00 
|
 Hall A5
 Chronischer Schmerz: viszeraler Schmerz
Chairs:  
Karl-Jürgen Bär, Germany
 Adriane Icenhour, Germany
Die Rolle viszeraler Schmerzen bei psychiatrischen 
Erkrankungen
 Karl-Jürgen Bär, Germany
Viszeraler Schmerz aus lerntheoretischer Perspek-
tive: neurobiologische Mechanismen und klinische 
Implikationen
 Adriane Icenhour, Germany
DGPPN 
General assembly 
Mon, 9 Oct 2017  
19:15 – 21:15 
 
Hall A8

© ThinkstockPhotos - Nelson A. Ishikawa
SPECIAL
 SESSIONS
40
eMEN Event
Getting in touch with digital interventions for 
mental health: practical insights for health 
professionals 
Online psychotherapy and e-mental health are on ev-
eryone's lips, but what is behind it? What technical 
possibilities are there? And how do these programmes 
work? In the context of this year's World Congress of 
Psychiatry renowned scientists will discuss the oppor-
tunities and risks of e-mental health and give an over-
view of the current state-of-the-art of science. This 
eMEN event addresses psychiatrists, psychotherapists, 
e-mental health developers and of course the interested
public. Psychiatrists and psychologists will report on 
their experiences with internet-based intervention 
during psychotherapy in their clinical routine. Another 
highlight of the event will be a start-up slam: Six inno-
vative companies will present their ideas for the digital 
support of psychotherapy. Finally, all presented e-mental 
health tools and programmes can be tested on site and 
discussed with the developers.
Thu, 12 Oct 2017 | Agenda
13:00 – 17:00 
|
 Hall New York 2
Chair: 
Wolfgang Gaebel, Chairman of the German Alliance for Mental Health, Germany
From 12:30 
Registration
13:15 – 13:20
Opening
Iris Hauth, Past President DGPPN, Germany
13:20 – 13:30
Welcome note
Oyono Vlijter, project leader of EU Project eMEN, Arq 
Foundation Diemen, The Netherlands
13:30 – 14:00
Keynote: Learning from Sweden: e-mental health 
in research and care
Gerhard Andersson, Linköping University, Sweden
14:00 – 14:15
Quality criteria for e-mental health in Germany
Jan Philipp Klein, University Medical Center 
Schleswig-Holstein in Lübeck, Germany
14:15 – 14:45 
|
 Coff ee break
14:45 – 15:05
Blended-care in clinical daily routine: experiences 
in Germany
Rüdiger Zwerenz, University Medical Center of the 
Johannes Gutenberg University Mainz, Germany
15:05 – 15:25
Self-help treatment programmes: prospects and 
boundaries
GET.ON Institute, Germany

SPECIAL
 SESSIONS
41
eMEN is a six country, e-mental health project funded by the Interreg North West Europe Innovation Programme, 
which will run until November 2019.  eMEN is led by the Netherlands with partners in Belgium, France, Germany, 
Ireland and the UK who combine technological, clinical, research and policy expertise. The project will undertake a 
unique combination of digital mental health activity in research, product development, policy and communications 
and create a legacy transnational e-mental health platform to unlock the power of technology to improve Europe's 
mental health. The project partners are pictured above.
15:25 – 15:45
Virtual reality: the third dimension of psychotherapy
Youssef Shiban, University of Regensburg, Germany
15:45 – 16:15 
|
 Coffee break
16:15 – 17:00
Start-up slam
Young companies present their technical solutions 
and ideas for the improvement of mental health care 
in 5-minute-intervals. During the breaks and after the 
event, there is the possibility to try out different e-men-
tal health programmes and get in touch with their de-
velopers.
Free simultaneous translation (German <-> English) via 
headphones is available. Please bring a deposit (e.g. ID 
card) to borrow these headphones. Participation is free 
of charge. As the number of participants is limited, we 
ask you to register in advance on:
www.dgppn.de/dgppn-akademie/termine/ 
e-mental-health.html

SPECIAL
 SESSIONS
42
The Geneva Prize and the Jean Delay Prize highlight the achievements for human rights and recognise exceptional 
research in psychiatry.
Geneva Prize for Human Rights in Psychiatry
The Geneva Prize for Human Rights in Psychiatry 
2017 is awarded to a non-governmental organi-
sation fighting for the rights of the mentally ill in 
Guatemala, ALAS PRO SALUD MENTAL
Founded in 2013, this organisation is at present the only 
NGO in Guatemala working to assist the access of the 
indigenous rural population to psychiatric care.
The Geneva Prize Jury particularly valued the work from 
among 15 candidates comprised of individuals, institu-
tions and NGOs. The President of the Jury, Luc Ciompi, 
Professor Emeritus of the Department of Social Psychi-
atry, University of Bern, Switzerland, drew attention to 
the fact that ALAS PRO SALUD MENTAL works in a 
particularly defavourised region of the world, dominat-
ed by poverty and violence and ravaged by a long civil 
war and by natural catastrophes (hurricanes). The Jury 
considered that the work of ALAS PRO SALUD MENTAL 
is courageous because of the real dangers which exist to 
those involved. This NGO has been successfully fighting 
for human rights in Guatemala against the stigma and 
discrimination from which the mentally ill suffer – thus 
fulfilling the specific objectives of the Geneva Prize. 
The Geneva Prize for Human Rights in Psychiatry was 
created in 1999 in Geneva, Switzerland on the occasion 
of the 50th anniversary of the Universal Declaration of 
Human Rights. In 2017 the 20,000 Swiss francs' Prize 
will be awarded for the 7
th
 time and will be presented to 
ALAS PRO SALUD MENTAL in Berlin in October 2017, 
on the occasion of the 17
th
 World Congress of Psychiatry.
The Board of Foundation of the Geneva Prize for Hu-
man Rights in Psychiatry is presided by François Ferrero, 
Professor Emeritus, University of Geneva, Switzerland. 
The Jury of the 2017 Prize comprised international per-
sonalities:
 
»
Marianne Kastrup, Denmark
 
»
 Elisabeth Decrey-Warner, President of the Geneva 
Call, Switzerland
 
»
 Dinesh Bhugra, President of the World Psychiatric 
Association, United Kingdom
 
»
 Pierre Vallon, President of the Swiss Federation of 
Psychiatry and Psychotherapy, Switzerland
 
»
 Robert Roth, Professor of Criminal Law, University of 
Geneva, Switzerland
 
»
 Olivier Vodoz, lawyer, former State Councillor, Geneva, 
Switzerland
Award Ceremony: 12 Oct 2017 
12:00 – 13:00 
|
 Hall A8
Laudation: 
François Ferrero, Switzerland 
Dinesh Bhugra, United Kingdom
Laureate: 
Jorge Alejandro Paiz Macz, Guatemala
Session: Closing Ceremony
Prize money: CHF 20,000
Awards
Recognition of excellent achievements